Works matching IS 10837159 AND DT 2014 AND VI 19 AND IP 4


Results: 26
    1

    Profiling Cancer Gene Mutations in Clinical Formalin-Fixed, Paraffin-Embedded Colorectal Tumor Specimens Using Targeted Next-Generation Sequencing.

    Published in:
    Oncologist, 2014, v. 19, n. 4, p. 336, doi. 10.1634/theoncologist.2013-0180
    By:
    • Zhang, Liangxuan;
    • Chen, Liangjing;
    • Sah, Sachin;
    • Latham, Gary J.;
    • Patel, Rajesh;
    • Song, Qinghua;
    • Koeppen, Hartmut;
    • Tam, Rachel;
    • Schleifman, Erica;
    • Mashhedi, Haider;
    • Chalasani, Sreedevi;
    • Fu, Ling;
    • Sumiyoshi, Teiko;
    • Raja, Rajiv;
    • Forrest, William;
    • Hampton, Garret M.;
    • Lackner, Mark R.;
    • Hegde, Priti;
    • Jia, Shidong
    Publication type:
    Article
    2

    To Treat or Not To Treat: Who Should Decide?

    Published in:
    Oncologist, 2014, v. 19, n. 4, p. 433, doi. 10.1634/theoncologist.2013-0258
    By:
    • Laarhoven, Hanneke W.M.;
    • Henselmans, Inge;
    • Haes, J. (Hanneke) C.
    Publication type:
    Article
    3
    4
    5

    Phase Ib of Sorafenib in Combination With Everolimus in Patients With Advanced Solid Tumors, Selected on the Basis of Molecular Targets.

    Published in:
    Oncologist, 2014, v. 19, n. 4, p. 344, doi. 10.1634/theoncologist.2013-0335
    By:
    • Toffalorio, Francesca;
    • Spitaleri, Gianluca;
    • Catania, Chiara;
    • Dal Zotto, Laura;
    • Noberasco, Cristina;
    • Delmonte, Angelo;
    • Santarpia, Mariacarmela;
    • Vecchio, Fabio;
    • Brunelli, Veronica;
    • Rampinelli, Cristiano;
    • Barberis, Massimo;
    • Fumagalli, Caterina;
    • Zucchetti, Massimo;
    • Zangarini, Monique;
    • Diena, Tullia;
    • Danesi, Romano;
    • Braud, Filippo;
    • De Pas, Tommaso
    Publication type:
    Article
    6

    Determination of Prognostic Factors in Japanese Patients With Advanced Gastric Cancer Using the Data From a Randomized Controlled Trial, Japan Clinical Oncology Group 9912.

    Published in:
    Oncologist, 2014, v. 19, n. 4, p. 358, doi. 10.1634/theoncologist.2013-0306
    By:
    • Takahari, Daisuke;
    • Boku, Narikazu;
    • Mizusawa, Junki;
    • Takashima, Atsuo;
    • Yamada, Yasuhide;
    • Yoshino, Takayuki;
    • Yamazaki, Kentaro;
    • Koizumi, Wasaburo;
    • Fukase, Kazutoshi;
    • Yamaguchi, Kensei;
    • Goto, Masahiro;
    • Nishina, Tomohiro;
    • Tamura, Takao;
    • Tsuji, Akihito;
    • Ohtsu, Atsushi
    Publication type:
    Article
    7
    8
    9

    Bosutinib in Combination With the Aromatase Inhibitor Letrozole: A Phase II Trial in Postmenopausal Women Evaluating First-Line Endocrine Therapy in Locally Advanced or Metastatic Hormone Receptor-Positive/HER2-Negative Breast Cancer.

    Published in:
    Oncologist, 2014, v. 19, n. 4, p. 348, doi. 10.1634/theoncologist.2014-0021
    By:
    • Moy, Beverly;
    • Neven, Patrick;
    • Lebrun, Fabienne;
    • Bellet, Meritxell;
    • Xu, Binghe;
    • Sarosiek, Tomasz;
    • Chow, Louis;
    • Goss, Paul;
    • Zacharchuk, Charles;
    • Leip, Eric;
    • Turnbull, Kathleen;
    • Bardy‐Bouxin, Nathalie;
    • Duvillié, Ladan;
    • Láng, István
    Publication type:
    Article
    10

    Alternative Response Criteria (Choi, European Association for the Study of the Liver, and Modified Response Evaluation Criteria in Solid Tumors [RECIST]) Versus RECIST 1.1 in Patients With Advanced Hepatocellular Carcinoma Treated With Sorafenib.

    Published in:
    Oncologist, 2014, v. 19, n. 4, p. 394, doi. 10.1634/theoncologist.2013-0114
    By:
    • Ronot, Maxime;
    • Bouattour, Mohamed;
    • Wassermann, Johanna;
    • Bruno, Onorina;
    • Dreyer, Chantal;
    • Larroque, Béatrice;
    • Castera, Laurent;
    • Vilgrain, Valérie;
    • Belghiti, Jacques;
    • Raymond, Eric;
    • Faivre, Sandrine
    Publication type:
    Article
    11
    12
    13
    14

    Learning From Gus.

    Published in:
    Oncologist, 2014, v. 19, n. 4, p. 437, doi. 10.1634/theoncologist.2013-0436
    By:
    • Shuman, Andrew G.
    Publication type:
    Article
    15

    Bosutinib in Combination With the Aromatase Inhibitor Exemestane: A Phase II Trial in Postmenopausal Women With Previously Treated Locally Advanced or Metastatic Hormone Receptor-Positive/HER2-Negative Breast Cancer.

    Published in:
    Oncologist, 2014, v. 19, n. 4, p. 346, doi. 10.1634/theoncologist.2014-0022
    By:
    • Moy, Beverly;
    • Neven, Patrick;
    • Lebrun, Fabienne;
    • Bellet, Meritxell;
    • Xu, Binghe;
    • Sarosiek, Tomasz;
    • Chow, Louis;
    • Goss, Paul;
    • Zacharchuk, Charles;
    • Leip, Eric;
    • Turnbull, Kathleen;
    • Bardy‐Bouxin, Nathalie;
    • Duvillié, Ladan;
    • Láng, István
    Publication type:
    Article
    16

    Randomized Phase II Trial Comparing Carboplatin Plus Weekly Paclitaxel and Docetaxel Alone in Elderly Patients With Advanced Non-Small Cell Lung Cancer: North Japan Lung Cancer Group Trial 0801.

    Published in:
    Oncologist, 2014, v. 19, n. 4, p. 352, doi. 10.1634/theoncologist.2013-0411
    By:
    • Maemondo, Makoto;
    • Inoue, Akira;
    • Sugawara, Shunichi;
    • Harada, Toshiyuki;
    • Minegishi, Yuji;
    • Usui, Kazuhiro;
    • Miwa, Koji;
    • Morikawa, Naoto;
    • Kambe, Mariko;
    • Ube, Kenji;
    • Watanabe, Kana;
    • Ishimoto, Osamu;
    • Sakakibara, Tomohiro;
    • Gemma, Akihiko;
    • Nukiwa, Toshihiro
    Publication type:
    Article
    17
    18
    19
    20
    21

    Low-Grade Gliomas.

    Published in:
    Oncologist, 2014, v. 19, n. 4, p. 403, doi. 10.1634/theoncologist.2013-0345
    By:
    • Forst, Deborah A.;
    • Nahed, Brian V.;
    • Loeffler, Jay S.;
    • Batchelor, Tracy T.
    Publication type:
    Article
    22
    23
    24
    25
    26